# Derivation of Tumor Specific Hybridomas

> **NCT01702792** · PHASE1 · TERMINATED · sponsor: **Dartmouth-Hitchcock Medical Center** · enrollment: 1 (actual)

## Conditions studied

- Glioblastoma

## Interventions

- **BIOLOGICAL:** Tumor Vaccine

## Key facts

- **NCT ID:** NCT01702792
- **Lead sponsor:** Dartmouth-Hitchcock Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-01
- **Primary completion:** 2015-05-06
- **Final completion:** 2015-05-06
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Investigator is leaving Dartmouth
- **Last updated:** 2018-04-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01702792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01702792, "Derivation of Tumor Specific Hybridomas". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01702792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*